RPS6KB1 and cancer: Dysregulation of the mTOR signaling, as reflected by elevated phosphorylation of eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase beta-1 (S6K1), has been reported in various cancers [216,217,218].